Japan· JP-3999462A1028
アニフロルマブ（遺伝子組換え）
A medicinal product containing アニフロルマブ（遺伝子組換え）, registered in Japan by アストラゼネカ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アニフロルマブ（遺伝子組換え）
- Manufacturer
- アストラゼネカ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
アニフロルマブ（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSAPHNELOAstraZeneca AB, Södertälje
- SwitzerlandSaphnelo 120 mg/0.8 ml, Injektionslösung in einem FertigpenAstraZeneca AG
- BelgiumSaphnelo 120 mgAstraZeneca
- FinlandSaphneloAstraZeneca AB
- IrelandSaphnelo 120 mg solution for injection in pre-filled penAstraZeneca AB
- IcelandSaphneloAstraZeneca AB*
- NetherlandsSaphnelo 120 mg oplossing voor injectie in een voorgevulde penAstraZeneca AB
- PolandSaphneloAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Saphnelo
- Liechtenstein · Saphnelo
- Norway · Saphnelo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ae6f6de-d5e3-49a3-8d34-397365724262 GET /v1/drugs/3ae6f6de-d5e3-49a3-8d34-397365724262?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３００ｍｇ２ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999462A1028",
"category": "注射薬",
"price_yen": 96068,
"generic_name": "アニフロルマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about アニフロルマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.